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Abstract
Background: The aim of this study was to investigate the role of TNF genetic variants and the
combined effect between TNF gene and cigarette smoking in the development of gastric cancer in
the Korean population.
Methods: We selected 84 incident gastric cancer cases and 336 matched controls nested within
the Korean Multi-Center Cancer Cohort. Six SNPs on the TNF gene, TNF-α-238 G/A, -308 G/A, -
857 C/T, -863 C/A, -1031 T/C, and TNF-β 252 A/G were genotyped. The ORs (95% CIs) were
calculated using unconditional logistic regression model to detect each SNP and haplotype-pair
effects for gastric cancer. The combined effects between the TNF gene and smoking on gastric
cancer risk were also evaluated. Multi dimensionality reduction (MDR) analyses were performed
to explore the potential TNF gene-gene interactions.
Results: TNF-α-857 C/T containing the T allele was significantly associated with an increased risk
of gastric cancer and a linear trend effect was observed in the additive model (OR = 1.6, 95% CI
1.0–2.5 for CT genotype; OR = 2.6, 95% CI 1.0–6.4 for TT genotype). All haplotype-pairs that
contained TCT or CCC of TNF-α-1031 T/C, TNF-α-863 C/A, and TNF-α-857 C/T were associated
with a significantly higher risk for gastric cancer only among smokers. In the MDR analysis,
regardless of smoking status, TNF-α-857 C/T was included in the first list of SNPs with a significant
main effect.
Conclusion: TNF-α-857 C/T polymorphism may play an independent role in gastric carcinogenesis
and the risk for gastric cancer by TNF genetic effect is pronounced by cigarette smoking.
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Background
Gastric cancer is a multi-factorial disease that requires the
study of environmental, genetics, and host-related factors
in order to understand its pathology. The strongest risk
factor for gastric cancer is Helicobacter pylori (H. pylori)
which is labeled a group I human gastric cancer carcino-
gen by the International Agency for Research on Cancer
[1]. However, a high prevalence of H. pylori infection does
not always result in a high incidence of gastric cancer.
Only a small portion of H. pylori infected persons have
gastric cancer, thereby suggesting that other susceptible
factors such as genetic variants or environmental differ-
ences must additionally be involved in gastric carcinogen-
esis.
Genetic variants of inflammation-related cytokines are a
potential risk factor because H. pylori infection induces
chronic inflammation in gastric mucosa which is a critical
step in gastric carcinogenesis. One of the major cytokines
associated with H. pylori infection is the tumor necrosis
factor (TNF) expressed by TNF-α and TNF-β genes [2-6].
Many studies have extensively investigated the association
between TNF and gastric cancer [5-15]. Although studies
have reported TNF can modify the risk of gastric cancer
[5,8-11], the exact role of TNF as a gastric carcinogen is
still controversial.
In terms of environmental factors, cigarette smoking has
been suggested to play a crucial role in increasing the risk
of gastric cancer. Previous epidemiologic studies indicated
that cigarette smoking was an independent risk factor for
gastric cancer development [16-21]. Moreover, cigarette
smoking may promote gastric cancer development by acti-
vating systemic inflammation [22]. Hamajima et al. pro-
posed that cigarette smoking and cytokines such as TNF-α
and Interleukin-1B may change normal mucosa to H. pylori
infected mucosa that may be a first step towards gastric
carcinogenesis [22].
Genetic variants of TNF cytokines and cigarette smoking
may play a role in gastric carcinogenesis. They seem to
play independent or synergetic roles in gastric cancer but
the mechanism is still unclear. Thus, we hypothesized that
genetic variants of TNF underlies the association with gas-
tric cancer risk and/or their combined effect with cigarette
smoking may modify the risk of gastric cancer. The aim of
this study was to assess the role of TNF gene variants and
the combined effect between TNF  genes and cigarette
smoking in the development of gastric cancer in the
Korean population.
Methods
Study population and data collection
In this population-based nested case-control study, we
selected subjects from the Korean Multi-Center Cancer
Cohort (KMCC), a prospective cohort of participants (N =
19,688) recruited from four urban and rural areas in
Korea (Haman, Chungju, Uljin, and Youngil) [23]. The
participants signed a consent form and completed a
detailed standardized interview-based questionnaire on
general lifestyle, diet, medical history, and other environ-
mental factors, and blood and spot urine samples were
collected and stored at -70°C and -20°C, respectively. All
information was from baseline survey questionnaires that
were collected before gastric cancer diagnosis. Cancer
ascertainment was identified by passive surveillance
through record linkages to the national cancer registry, the
national death certificate, and the health insurance medi-
cal records databases [23]. A total of 136 gastric cancer
cases were ascertained in December 2002. Of the 136
cases, 36 cases diagnosed before recruitment and 16 cases
that lacked DNA for genotyping were excluded. Eligible
non-cancer controls were randomly selected from the
KMCC population. Four controls were matched to each
gastric cancer case by four variables that were age (± 5
years), sex, residential district, and enrollment year.
Finally, 84 gastric cancer cases and 336 controls were
included in this study.
Genotyping
TNF-α gene was genotyped for five single nucleotide pol-
ymorphisms (SNPs) that were -238 G/A(rs361525), -308
G/A(rs1800629), -857 C/T(rs1799724), -863 C/
A(rs1800630), and -1031 T/C(rs1799964). These five pol-
ymorphisms were located in the promoter region of TNF-
α gene. The TNF-β gene that is synonymous with Lym-
photoxin-α (LTA) was genotyped for 252 A/G (rs909253)
SNP. Genotyping was performed using SNaPshot
method. Ten samples were randomly selected and geno-
typed for each SNP to check for reliability. All assays were
100% concordant. More than 95% of the total subjects
were successfully genotyped for all SNPs.
H. pylori serum assays
Serum was evaluated to identify IgG antibodies specific
for H. pylori and seropositivity of CagA/VacA by Helico
Blot 2.1™ (MP Biomedicals Asia Pacific, Singapore)
according to the manufacturer's protocol. [24,25]. The
sensitivity and specificity for detecting seropositivity of H.
pylori, CagA and VacA of Helico Blot 2.1™ were very high
(for sensitivity, 99%, 99% and 93%, respectively; for spe-
cificity, 98%, 90% and 88%, respectively) [26].
Statistical analysis
Unconditional logistic regression model was used to cal-
culate the odds ratios (ORs) and 95% confidence intervals
(95% CIs) of selected characteristics such as follow time
(years), H. pylori seropositivity, alcohol consumption, and
cigarette smoking status for gastric cancer risk. To evaluate
significant covariates, we reviewed the literature and con-BMC Cancer 2009, 9:238 http://www.biomedcentral.com/1471-2407/9/238
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ducted logistic regression analysis; smoking status, H.
pylori  infection, and CagA seropositivity were selected.
Because of the significant association between age/sex and
smoking status, we also included age and sex as major
covariates. In the analysis, all five covariates were selected
adjusted variables, and smoking status was also selected as
a stratified variable.
The Hardy-Weinberg equilibrium assessed allele frequen-
cies using the chi-square test. Both single SNPs and haplo-
type analysis were performed. To detect each SNP effect
for gastric cancer, three genetic models, dominant, co-
dominant and additive model, were used. Tests for signif-
icance were computed after adjusting for age, sex, smok-
ing status, H. pylori infection, and CagA seropositivity.
Also, in order to correct for multiple comparisons, false
discovery rate (FDR) that controls the expected propor-
tion of incorrectly rejected null hypotheses (type I errors)
was computed [27].
To evaluate putative haplotype blocks, linkage disequilib-
rium (LD) between loci expressing genetic variation was
analyzed using Haploview 4.0. Moreover, pairwise
Lewontin's D' and r2 values were calculated with 95% CIs
when the genotype frequencies were in Hardy-Weinberg
equilibrium [28]. Three haplotype blocks were generated
which included the following: 1) only three TNF-α SNPs -
857, -863, and -1031; 2) three TNF-α SNPs in block 1 and
TNF-β 252; and 3) all six SNPs on TNF-α and TNF-β were
generated by the Haploview software using the method
suggested by Gabriel et al [29] (Additional file 1).
Based on haplotype analysis, each individual haplotype-
pair was estimated with haplotype frequencies greater
than 5%. We stratified according to smoking status to
assess the combined effect of the TNF gene and smoking
for gastric cancer. To evaluate the association between risk
for gastric cancer and TNF haplotype-pairs effects, uncon-
ditional logistic regression model was used to calculate
the ORs and 95% CIs with adjustment for age, sex, H.
pylori infection and CagA seropositivity.
Multi dimensionality reduction (MDR) analyses were per-
formed to explore the potential TNF gene-gene interac-
tions. MDR is a non-parametric data mining approach for
detecting a potential gene-gene or gene-environment
interaction and providing selective models of high-order
combination of genes [30,31]. MDR methodology is
described in detail elsewhere [30-32]. TNF  gene-gene
interaction was evaluated using a naïve Bayes classifier in
the context of a 10-fold cross-validation to estimate the
test accuracy (TA) of the best 1-, 2-, 3-, and 4- factor mod-
els (Additional file 2). The best single interaction model
was selected by maximized TA, lowest prediction error or
higher cross-validation consistency (CVC). Significance
was evaluated using a sign test and was determined at the
0.05 level. Finally, we conducted logistic regression to
assess the association between genotype combinations
suggested by MDR and gastric cancer with the MDR ORs
and 95% CIs. According to stratification by smoking sta-
tus, MDR ORs were also calculated after adjusting for age,
sex, H. pylori infection and CagA seropositivity. All statis-
tical analyses using logistic regression models were per-
formed with SAS version 9.1 and MDR analyses were
implemented using MDR software version 11.0 (available
at http://www.epistasis.org).
IRB approval
The study protocols for the KMCC study and the present
nested case-control study were approved by the institu-
tional review boards of Seoul National University Hospi-
tal and the National Cancer Center of Korea (H-0110-
084-002, and C-0603-161-170, respectively).
Results
Table 1 presents the odds ratios and 95% CIs of the
selected characteristics for gastric cancer risk. There was no
significant difference between cases and controls accord-
ing to age, gender, median follow up period (FU years),
education level, H. pylori infection, CagA/VacA seroposi-
tivity, and alcohol consumption. All smoking related fac-
tors were associated with an increased risk for gastric
cancer. Current smokers had a significantly higher risk for
gastric cancer compared to never smokers (OR = 1.8, 95%
CI 1.0–3.2). Moreover, a dose-response relationship
between smoking intensity and gastric cancer risk was
found. Smoking more cigarettes per day in addition to
longer smoking duration showed a significantly higher
risk compared to never smokers (OR = 3.9, 95% CI 1.4–
10.7 for more than 20 cigarettes per day; OR = 1.9, 95%
CI 1.1–3.5 for more than 20 years). 41 or more pack-years
of smoking was related to a statistically increased risk for
gastric cancer (OR = 2.3, 95% CI 1.1–4.9).
Table 2 shows the distribution of TNF polymorphisms
among cases and controls and the ORs (95% CIs) for gas-
tric cancer risk in relation to TNF genetic polymorphisms.
All genotype frequencies of each SNP did not deviate from
the Hardy-Weinberg equilibrium (p > 0.1). In single SNPs
analysis, TNF-α-857 C/T containing the T allele was signif-
icantly associated with an increased risk of gastric cancer.
CT genotype of TNF-α-857 showed a 1.7 fold increased
risk for gastric cancer in the co-dominant and dominant
models that were statistically significant (95% CI 1.0–2.8,
identically in both models). However the TT genotype of
TNF-α-857 showed an insignificantly increased risk in the
co-dominant model (OR = 1.7, 95% CI 0.3–9.2). In the
additive model which showed a linear trend effect, the CT
genotype of TNF-α-857 showed a 1.6 fold increased risk
for gastric cancer (95% CI 1.0–2.5) and the TT genotypeBMC Cancer 2009, 9:238 http://www.biomedcentral.com/1471-2407/9/238
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Table 1: Odds ratios and 95% CIs for gastric cancer risk according to basic characteristics of study subjects in a nested case-control 
study within the KMCC 19,688 enrolled cohort members.
Case
(N = 84)
Control
(N = 336)
OR (95% CI)
Sex
Male 59 (70) 236 (70) 1.0 (reference)
Female 25 (30) 100 (30) 1.0 (0.6–1.7)
Agea
≤ 63 years old 43 (51) 176 (52) 1.0 (reference)
> 63 years old 41 (49) 160 (48) 1.1 (0.7–1.7)
Follow upb
≤ 6 years for FU 47 (56) 188 (56) 1.0 (reference)
> 6 years for FU 37 (44) 148 (44) 1.0 (0.6–1.6)
Education level
without any schooling 22 (26) 98 (29) 1.0 (reference)
schooling 62 (74) 237 (71) 1.2 (0.7–2.0)
H. pylori infection
negative (-) 12 (14) 48 (14) 1.0 (reference)
positive (+) 72 (86) 288 (86) 1.0 (0.5–2.0)
CagA
negative (-) 11 (13) 54 (16) 1.0 (reference)
positive (+) 73 (87) 282 (84) 1.3 (0.6–2.5)
VacA
negative (-) 36 (43) 156 (46) 1.0 (reference)
positive (+) 48 (57) 180 (54) 1.2 (0.7–1.9)
Drink statusc
Never drinkers 38 (45) 144 (43) 1.0 (reference)
Ever drinkers 46 (55) 188 (57) 0.9 (0.6–1.5)
Smoking status
Never smokers 26 (31) 141 (42) 1.0 (reference)
Ex smokers 21 (25) 82 (25) 1.4 (0.8–2.6)
Current smokers 37 (44) 111 (33) 1.8 (1.0–3.2)*
Cigarette per day
Never smokers 26 (31) 141 (42) 1.0 (reference)
20 ≤ 15 (18) 59 (18) 1.4 (0.7–2.8)
>20 8 (9) 11 (3) 3.9 (1.4–10.7)**
unreported 35 (42) 125 (37) 1.5 (0.9–2.7)
Smoking duration (years)
Never smokers 26 (31) 141 (42) 1.0 (reference)
20 ≤ 5 (6) 29 (9) 0.9 (0.3–2.6)
>20 32 (38) 88 (26) 1.9 (1.1–3.5)*
unreported 21 (25) 78 (23) 1.5 (0.8–2.8)
Pack-Yeard
Never smokers 26 (31) 141 (42) 1.0 (reference)
20< 5 (6) 14 (4) 1.9 (0.6–5.8)
20–40 8 (10) 40 (12) 1.1 (0.5–2.6)
≥ 41 14 (17) 33 (10) 2.3 (1.1–4.9)*
unreported 31 (36) 108 (32) 1.6 (0.9–2.8)
* p < 0.05, ** p < 0.01
a. Median age for cases and controls was 63 years. Age ranged from 40.0 to 83.0 years old.
b. The median year for follow up was 6 years. Number of follow-up years ranged from 2 to 8 years.
c. Ever drinkers defined as former and current drinkers.
d. Pack years was calculated by the equation, (number of cigarettes smoked per day × number of years smoked)/20BMC Cancer 2009, 9:238 http://www.biomedcentral.com/1471-2407/9/238
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of TNF-α-857 had a 2.6 fold increased risk (95% CI 1.0–
6.4). Both increase risks for the T allele in the additive
model were statistically significant. Under multiple com-
parison tests by FDR, all p-values of TNF SNPs in each
additive model were greater than 0.2.
Table 3 shows the association between haplotype-pairs of
TNF gene and gastric cancer risk according to smoking sta-
tus. In block 1 that is composed of TNF-α-1031 T/C, TNF-
α-863 C/A and TNF-α-857 C/T (D' = 1.0 and r2 = 0.037),
compared to TCC-TCC without a variant allele, TCC-TCT
showed a significantly increased risk for gastric cancer
among total subject and smokers (OR = 2.1, 95% CI 1.1–
3.9; OR = 2.6, 95% CI 1.2–5.8; respectively) but was not
associated with gastric cancer risk among non-smokers
(OR = 1.5, 95% CI 0.5–4.0). TCC-CCC was associated
with an increased risk only among smokers (OR = 2.9,
95% CI 1.0–8.9). Similar results were represented in block
2 that is composed of the three TNF-α SNPs in block 1 and
TNF-β 252 A/G (D' = 1.0 and r2 = 0.184), and block 3 that
is composed of all six TNF SNPs (D' = 1.0 and r2 = 0.068).
Compared to the most frequent haplotype-pairs GTCC-
GTCC in block 2, ATCT-XXXX or ACCC-XXXX that con-
tained TCT or CCC of TNF-α-1031 T/C, TNF-α-863 C/A
and  TNF-α-857 C/T showed a significantly higher risk
among smokers but not among non-smokers (OR = 2.5,
95% CI 1.0–6.8 for ATCT haplotype-pairs; OR = 4.1, 95%
CI 1.2–14.2 for ACCC haplotype-pairs). Particularly,
among non-smokers, other haplotype-pairs which did not
contain ATCT or ACCC were associated with a signifi-
cantly reduced risk for gastric cancer compared to the ref-
erence haplotype-pairs (OR = 0.2, 95% CI 0.1–0.7).
Similarly for block 1 and 2, ATCTGG or ACCCXX haplo-
type-pairs that contained TCT or CCC of TNF-α-1031 T/C,
TNF-α-863 C/A and TNF-α-857 C/T were also associated
with a significantly higher risk for gastric cancer only
among smokers (OR = 3.1, 95% CI 1.0–10.0 for ATCTGG;
OR = 4.7, 95% CI 1.2–18.2 for ACCCXX).
Table 4 presents the summary of MDR analysis and asso-
ciation between high risk genotype combinations sug-
gested by MDR analysis and gastric cancer risk. We
selected separate best models according to smoking status.
The best MDR model for TNF SNPs among total subjects
included TNF-α-1031 T/C, TNF-α-863 C/A, TNF-α-857 C/
T and TNF-α-308. This model had maximum TA of 0.602
and maximum CVC of 9/10 (p = 0.0015). The global OR
adjusted for the age, sex, smoking status, H. pylori infec-
tion, and CagA seropositivity was 2.2 (95% CI 1.3–3.6).
Regardless of smoking status, TNF-α-857 C/T was
included in the first list of SNPs with a significant main
effect. TNF-α-857 model among total subjects had TA of
0.554 and CVC of 9/10 but was not significant at the level
of 0.0799. Similar results were shown among non-smok-
ers and smokers. Among non-smokers, the model
included only TNF-α-857 and had a maximum CVC of 9/
Table 2: The association between genetic polymorphisms of TNF and risk of gastric cancer in a nested case-control study within the 
KMCC 19,688 enrolled cohort members.
OR (95% CI)a
Gene Genotype Case Control Co-dominant Dominant Additive raw p valueb
TNF β 252 A/G (rs909253) AA 23 (29) 83 (26) 1.0 (reference) 1.0 (reference) 1.0 (reference)
AG 43 (54) 170 (54) 0.9 (0.5–1.6) 0.9 (0.5–1.5) 0.9 (0.6–1.3) 0.5110
GG 13 (17) 61 (20) 0.8 (0.4–1.7) 0.8 (0.4–1.7)
TNF α-1031 T/C (rs1799964) TT 55 (66) 205 (63) 1.0 (reference) 1.0 (reference) 1.0 (reference)
TC 25 (30) 109 (34) 0.8 (0.5–1.4) 0.8 (0.5–1.4) 0.9 (0.6–1.4) 0.5915
CC 3 (4) 10 (3) 1.1 (0.3–4.3) 0.9 (0.3–1.9)
TNF α-863 C/A (rs1800630) CC 64 (77) 227 (70) 1.0 (reference) 1.0 (reference) 1.0 (reference)
CA 16 (19) 90 (28) 0.6 (0.3–1.1) 0.7 (0.4–1.2) 0.8 (0.5–1.3) 0.3416
AA 3 (4) 6 (2) 1.6 (0.4–6.9) 0.6 (0.2–1.7)
TNF α-857 C/T (rs1799724) CC 49 (58) 227 (70) 1.0 (reference) 1.0 (reference) 1.0 (reference)
CT 33 (39) 92 (28) 1.7 (1.0–2.8)* 1.7 (1.0–2.8)* 1.6 (1.0–2.5)* 0.0466
TT 2 (3) 6 (2) 1.7 (0.3–9.2) 2.6 (1.0–6.4)*
TNF α-308 G/A (rs1800629)c GG 75 (90) 288 (89) 1.0 (reference) 1.0 (reference) 1.0 (reference)
GA 8 (10) 34 (11) 0.8 (0.4–1.9) 0.8 (0.3–1.7) 0.7 (0.3–1.6) 0.4439
AA - - - 0.5 (0.1–2.5)
TNF a-238 G/A (rs361525)c GG 73 (88) 305 (92) 1.0 (reference) 1.0 (reference) 1.0 (reference)
GA 10 (12) 26 (8) 1.6 (0.7–3.6) 1.6 (0.7–3.6) 1.6 (0.7–3.6) 0.2333
AA - - - 2.5 (0.5–12.1)
* p < 0.05, ** p < 0.01
a. Adjusted for age, sex, smoking status (Never vs. Ever), H. Pylori infection, and CagA seropositivity.
b. Calculated by likelihood ratio test in each additive model. FDR adjusted p-values for all SNPs were not significant (p > 0.2).
c. Excluded mutant genotype (AA genotype) frequency less than 1% or totally 0%.BMC Cancer 2009, 9:238 http://www.biomedcentral.com/1471-2407/9/238
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10 and a higher prediction for gastric cancer risk of (OR =
1.7, 95% CI 1.0–2.7) though showing minimum TA of
0.603 (p  = 0.0636). In contrast, although the model
included TNF-β 252 A/G, TNF-α-1031 T/C, TNF-α-857 C/
T, and TNF-α-308 G/A had a higher CVC of 8/10 and max-
imum TA of 0.697 (p = 0.0009), it had a lower predictabil-
ity for gastric cancer risk since the adjusted global OR by
this model was not significant (OR = 1.2, 95% CI 0.7–
2.0). The best model of smokers was selected with TNF-α-
1031 T/C, TNF-α-863 C/A and TNF-α-857 C/T. This
model had a maximum CVC of 10/10, TA of 0.615 (p =
0.0023) and adjusted global OR of 2.0 (95% CI 1.2–3.3).
Although the model included TNF-α-1031 T/C, TNF-α-
863 C/A, TNF-α-857 C/T, and TNF-α-308 G/A had maxi-
mum TA with the lowest p value, its CVC was relatively
low (7/10).
Discussion
In our study, TNF-α-857 C/T genetic variant containing
the T allele was associated with a significantly increased
risk for gastric cancer. SNP-SNP interaction in the TNF
gene including TNF-α-857 C/T or TNF-α-1031 T/C
genetic variant was associated with a risk for gastric cancer
among smokers but not among non-smokers. Moreover
this effect of the TNF-α-857 C/T genetic variant was ascer-
tained in both haplotype and MDR analysis.
Previous studies reported that TNF gene polymorphisms
modified the risk of gastric cancer [5,8-11], while others
did not find a significant association [6,7,12-15]. This
inconsistency may be due to the small number of cases,
differences in ethnic populations and SNP selection. Two
recent meta-analyses assessed the association between
TNF-α polymorphisms and risk of gastric cancer [33,34].
According to these papers, TNF-α-308 polymorphism had
a significantly increased risk for gastric cancer but TNF-α-
857 polymorphism only showed a marginally significant
risk due to the small number of studies. In contrast to the
meta-analysis, our results indicated that TNF-α-857 poly-
morphism was associated with a significantly increased
risk for gastric cancer but other SNPs including TNF-α-308
did not show a significant association. Our findings about
Table 3: Haplotype-pairs effects of TNF genetic polymorphisms for gastric cancer stratified by smoking status in a nested case-control 
study within the KMCC 19,688 enrolled cohort members.
Haplotype pairs Total Non-smokers Smokers
Case Control OR (95% CI)a Case Control OR (95% CI)b Case Control OR (95% CI)b
Block1: TNF α-1031, -863, -857c
TCC-TCC 25 (34) 132 (44) 1.0 (reference) 11 (50) 58 (45) 1.0 (reference) 14 (27) 73 (44) 1.0 (reference)
TCC-TCT 28 (38) 72 (24) 2.1 (1.1–3.9)* 9 (41) 33 (26) 1.5 (0.5–4.0) 19 (37) 38 (23) 2.6 (1.2–5.8)*
TCC-CCC 7 (10) 20 (7) 1.7 (0.6–4.6) 0 (0) 8 (6) 0.3 (0.0–5.6)d 7 (14) 12 (7) 2.9 (1.0–8.9)*
TCC-CAC 13 (18) 73 (25) 0.9 (0.4–1.9) 2 (9) 29 (23) 0.3 (0.1–1.7) 11 (22) 44 (26) 1.3 (0.5–3.1)
Block2: TNF β 252, α-1031, -863, -857
GTCC-GTCC 15 (18) 71 (21) 1.0 (reference) 9 (35) 30 (22) 1.0 (reference) 6 (10) 40 (21) 1.0 (reference)
ATCT-XXXX e 35 (42) 101 (31) 1.7 (0.8–3.3) 13 (50) 41 (30) 1.0 (0.4–2.9) 22 (38) 59 (31) 2.5 (1.0–6.8)*
ACCC-XXXX f 8 (9) 24 (7) 1.5 (0.6–4.2) 0 (0) 11 (8) 0.1 (0.0–2.6)d 8 (14) 13 (7) 4.1 (1.2–14.2)**
Others 26 (31) 137 (41) 0.9 (0.4–1.8) 4 (15) 57 (41) 0.2 (0.1–0.7)* 22 (38) 80 (42) 1.9 (0.7–5.0)
Block3: all TNF 6 SNPsg
GTCCGG* GTCCGG 10 (12) 57 (17) 1.0 (reference) 6 (23) 24 (17) 1.0 (reference) 4 (7) 32 (17) 1.0 (reference)
ATCTGG-XXXXXX h 34 (40) 91 (27) 2.1 (0.9–4.7) 13 (50) 37 (26) 1.4 (0.5–4.3) 21 (36) 53 (27) 3.1 (1.0–10.0)*
ACCCXX-XXXXXX i 8 (10) 24 (7) 1.8 (0.6–5.2) 0 (0) 11 (8) 0.2 (0.0–3.2)d 8 (14) 13 (7) 4.7 (1.2–18.2)*
ACACGG-XXXXXX j 12 (14) 55 (16) 1.1 (0.5–2.9) 2 (8) 21 (15) 0.3 (0.1–2.0) 10 (17) 34 (17) 2.3 (0.7–8.2)
Others 20 (24) 108 (33) 1.0 (0.4–2.4) 5 (19) 47 (34) 0.4 (0.1–1.6) 15 (26) 61 (32) 1.9 (0.6–6.3)
* p < 0.05, ** p < 0.01
a. Adjusted for age, sex, H. Pylori infection, CagA seropositivity, and smoking status (Never vs. Ever).
b. Adjusted for age, sex, H. Pylori infection, and CagA seropositivity.
c. If frequency of haplotype pairs among controls was less than 5%, we did not include in the logit model.
d. Logit estimate for OR and 95% CI.
e. Haplotype pairs were ATCT-GTCC, ATCC-ATCT, ATCT-ATCT and ATCT-ACAC.
f. Haplotype pairs were ATCC-ACCC, ACCC-ACAC and ACCC-GTCC.
g. All SNPs, TNF β 252, TNF α-1031, TNF α-863, TNF α-857, TNF α-238 and TNF α-308, were included to estimate individual haplotypes.
h. Haplotype-pairs were ATCTGG-GTCCGG, ATCCGG-ATCTGG, ATCTGG-ATCTGG, ATCTGG-ACCCAG, ATCTGG-ACACGG and 
ATCTGG-ATCCAA.
i. Haplotype-pairs were ACCCGG-ACACGG, ACCCAG-ACACGG, ACCCAC-GTCCGG, ACCCAC-GTCCGA and ATCCGG-ACCCAG.
j. Haplotype-pairs were ACACGG-ACACGG, ACACGG-GTCCGG and ACACGG-GTCCGA.BMC Cancer 2009, 9:238 http://www.biomedcentral.com/1471-2407/9/238
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the single SNP effect of TNF-α-857 polymorphism can
help clarify results of the previous meta-analyses. Incon-
sistency in TNF-α-308 polymorphism may be due to an
ethnic difference since TNF-α-308 AA polymorphism is
rare in the East Asian population. Also, we were not able
to clearly evaluate TNF-α-308 AA polymorphism and gas-
tric cancer because none of our gastric cancer cases had the
TNF-α-308 AA polymorphism.
In haplotype-pairs and MDR analysis, we observed a
genetic combined effect among TNF  SNPs. Individual
haplotype-pairs including TNF-α-1031, -863 and -857
were consistently associated with a significantly increased
risk of gastric cancer. Compared to the single SNP effect of
the TNF-α-857 polymorphism, a greater odds ratio for
haplotype-pairs including TNF-α-857 indicated that a
synergistic interaction among TNF  SNPs was more
strongly associated with gastric cancer development.
These results were nearly replicated in the MDR analysis.
Our consistent findings from the different statistical
methodologies are quite meaningful.
TNF cytokine may interact with cigarette smoking to pro-
mote gastric cancer development. Biologically, cigarette
smoking can activate systemic inflammations [35] and
augment the level of TNF-α through changes in inflam-
matory markers or cytokine level in animal models [36-
38]. Although these findings have not been fully repro-
duced in humans, several papers suggest an indirect con-
nection between cigarette smoking and TNF gene in the
etiology of gastric cancer [39-42]. Some studies reported
that circulating concentrations of TNF-α were increased
and higher TNF-α level was associated with such diseases
in smokers compared to non-smokers [39-42]. In one of
these studies, higher TNF-α levels were presented among
smokers, especially subjects with the 857 T allele and rare
haplotype of the TNF-α promoter [39]. Similar to our
findings, the study concluded that TNF-α-857 polymor-
phism was especially susceptible to the hazards of smok-
Table 4: MDR analysis for TNF SNPs and risk of gastric cancer associated with selected combination in MDR stratified by smoking 
status in a nested case-control study within the KMCC 19,688 enrolled cohort members.
Test accuracy CVCa p value b Case Control OR (95% CI)c
Total α-857 0.554 9/10 0.0799 49 (58) 227 (70) 1.0 (reference)
35 (42) 98 (30) 1.7 (1.0–2.8)*
α-857, α-308 0.577 6/10 0.0225 42 (51) 207 (65) 1.0 (reference)
41 (49) 110 (35) 1.8 (1.1–3.0)*
α-863, α-857, α-308 0.591 6/10 0.0044 42 (51) 215 (70) 1.0 (reference)
40 (49) 94 (30) 2.2 (1.3–3.7)**
α-1031, α-863, α-857, α-308d 0.602 9/10 0.0015 36 (44) 193 (63) 1.0 (reference)
46 (56) 113 (37) 2.2 (1.3–3.6)**
Non-smokers α-857 0.603 9/10 0.0636 49 (58) 227 (70) 1.0 (reference)
35 (42) 98 (30) 1.7 (1.0–2.7)*
α-857, α-308 0.664 6/10 0.0038 42 (51) 207 (65) 1.0 (reference)
41 (49) 110 (35) 1.8 (1.1–3.0)*
β 252, α-857, α-308 0.680 6/10 0.0030 34 (43) 158 (52) 1.0 (reference)
45 (57) 143 (48) 1.5 (0.9–2.4)
β 252, α-1031, α-857, α-308 0.697 8/10 0.0009 40 (51) 165 (56) 1.0 (reference)
39 (49) 130 (44) 1.2 (0.7–2.0)
Smokers α-857 0.554 6/10 0.1863 51 (61) 233 (72) 1.0 (reference)
33 (39) 92 (28) 1.6 (1.0–2.7)*
α-1031, α-857 0.570 7/10 0.0130 32 (39) 151 (48) 1.0 (reference)
51 (61) 165 (52) 1.4 (0.9–2.4)
α-1031, α-863, α-857d 0.615 10/10 0.0023 42 (51) 210 (68) 1.0 (reference)
40 (49) 101 (32) 2.0 (1.2–3.3)**
α-1031, α-863, α-857, α-308 0.662 7/10 0.0015 43 (52) 215 (70) 1.0 (reference)
39 (48) 91 (30) 2.1 (1.3-3.5)**
* p < 0.05, ** p < 0.01
a. Cross-validation consistency
b. P-values were estimated by sign test.
c. Among total subjects, the ORs (95% CIs) were adjusted for age, sex, smoking status (Never vs. Ever), H. Pylori infection, and CagA seropositivity, 
and after stratification for smoking status, the ORs (95% CIs) were adjusted for age, sex, H. Pylori infection, and CagA seropositivity, except smoking 
status.
d. Overall best model attributed by the MDR methodBMC Cancer 2009, 9:238 http://www.biomedcentral.com/1471-2407/9/238
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ing and the TNF  cytokine was strongly affected by
cigarette smoking.
The combined effect between smoking and TNF gene was
definitely expressed in our haplotype-pairs and MDR
analysis. Haplotype-pairs formed with TNF-α-1031, -863
and -857 were associated with a significantly greater
increased risk for gastric cancer only among smokers but
not among non-smokers. Both single SNP and haplotype-
pair effect of TNF-α-857 T allele were related with an
increased risk among smokers. Haplotype-pairs including
TNF-α-1031 and -863 genetic variation that did not show
significance for single SNP effect were also associated with
a significantly increased risk of gastric cancer among
smokers only. In contrast to TNF-α-857, TNF-α-1031 and
-863 may interact mutually based on haplotype specificity
and not allele specificity, and this effect may be strongly
affected by smoking. If only allele specificity by high-pro-
ducing or mutant alleles plays a role as risk factors for gas-
tric cancer, haplotype-pairs composed of a greater number
of high-producing or mutant alleles may have an even
greater risk. Based on this hypothesis, CAT haplotype
should be the most powerful risk factor for gastric cancer
development and CAC haplotype composed of two high-
producing alleles should show a greater risk than CCC or
TCT haplotype that includes only one high-producing
allele. However, we were not able to fully test this hypoth-
esis because only four haplotypes, TCC, TCT, CCC and
CAC, were observed in our population. Considering our
results, independent allele specificity of TNF-α-857 T and
mutual haplotype specificity of TNF-α-1031 and -863
may be more important risk factors rather than the total
number of high-producing alleles, especially for smokers.
Moreover, these results were reproduced in all hap-
loblocks regardless of different SNP combinations and
were nearly replicated in the MDR analysis. This supports
our conclusion that the interaction between the TNF gene
and smoking may play a crucial role in the etiology of gas-
tric cancer.
Although, to our knowledge, this is the first study to
report an interaction between the TNF gene and cigarette
smoking on gastric cancer development, our study had
several limitations. First, because of a small number of
gastric cancer cases and small sample size, we did not have
sufficient statistical power and were not able to stratify on
different factors. Second, although we had information on
cardiac or non-cardiac cancer of gastric cancer cases,
because of our small number of cases, we were not able to
observe a difference for gastric cancer risk according to
cancer type. Moreover, we did not collect information on
cancer histology. Finally, a part of SNPs which is related to
signal pathway (NF-κB) from H. pylori to cytokine gene
expression were genotyped. Other cytokines, such as inter-
leukins and GM-CSF, which are involved in NF-κB path-
way, were not considered for analysis so we examined
only a small portion of signal pathway for gastric carcino-
genesis.
In spite of these limitations, our study had several
strengths. This is a population-based, nested case-control
study that is free of biases that are common in retrospec-
tive studies. Additionally, we matched cases and controls
according to basic confounders, such as age and sex, and
significant confounding factors selected in the full model.
Furthermore, we used various approaches to detect the
potential association between genetic and environmental
factors on gastric cancer, and derived consistent results
through different approaches. Finally, the minor allele fre-
quencies (MAFs) of all cytokine genes analyzed in our
study showed very similar results in the Korean, Chinese,
and Japanese Hapmap projects [43,44] and thus, our
results are applicable to most East-Asian populations. On
the basis of this study results, we will be able to make
more conclusive evidence in future studies.
Conclusion
This study demonstrates that TNF-α-857 C/T polymor-
phism may play an independent role in gastric carcino-
genesis and the gene-gene interaction of TNF also affects
gastric cancer development. The combined effect between
TNF gene and cigarette smoking can be a major risk factor
for gastric cancer. Tailored smoking cessation programs
should be targeted for smokers with TNF genetic variants.
Additional studies with a greater number of cases and
information about gastric cancer type and various genes
will allow us to conduct stratified analysis to obtain more
detailed results that will further clarify the role of genetic
and environment factors on gastric cancer.
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